Press Releases

WBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.

WBB Securities is a sponsor of this year’s Future Leader’s conference.

WBB Securities acted as co-manager to a transaction for Cempra Pharmaceuticals, a clinical-stage biopharmaceutical company focused on discovering and developing novel antibiotics.

WBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.

WBB Securities acted as financial advisor to Navidea Biopharmaceuticals regarding a term loan with CRG (formerly Capital Royalty LP). Under the terms of the agreement, CRG will provide Navidea with initial funding of $50[...]

WBB Securities acted as placement agent to a transaction for Cytori Therapeutics, a clinical-stage biopharmaceutical company focused on discovering and developing autologous cell therapies from adipose tissue to treat a variety of medical conditions.

Today WBB Securities sponsored BioCentury’s Future Leaders in the Biotech Industry conference held at the Millennium Broadway Hotel and Conference Center in New York City.

WBB Securities acted as co-manager to a transaction for Omeros Corporation in an underwritten public offering that closed on February 3, 2015.

CytoSorbents announces closing of public offering to fund ongoing commercial and clinical activities

WBB Securities is pleased to announce that Michelle Thomas, CRCPhas been elected to the FINRA District 2 Committee where she will serve a three-year term.